Pages that link to "Q36467826"
Jump to navigation
Jump to search
The following pages link to Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial (Q36467826):
Displaying 31 items.
- How grim is hepatocellular carcinoma? (Q27001669) (← links)
- A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinoma (Q33493146) (← links)
- Systemic chemotherapy of liver tumors (Q34110952) (← links)
- Primary liver tumors (Q34110964) (← links)
- Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis (Q34998414) (← links)
- Systemic therapies for hepatocellular carcinoma. (Q35964708) (← links)
- Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma (Q36671639) (← links)
- Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinoma (Q36945072) (← links)
- Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now. (Q38056849) (← links)
- Immunotherapy in hepatocellular carcinoma: Primed to make a difference? (Q38628638) (← links)
- A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma. (Q40558434) (← links)
- No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinoma (Q40691152) (← links)
- Etiology, screening, and treatment of hepatocellular carcinoma (Q41109723) (← links)
- Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials (Q41419107) (← links)
- Nonresectional therapies for hepatocellular carcinoma (Q41459549) (← links)
- Practical considerations in the treatment of hepatocellular carcinoma. (Q41733369) (← links)
- Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha (Q41814612) (← links)
- Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future (Q42343451) (← links)
- Evolution of systemic therapy of advanced hepatocellular carcinoma (Q42617015) (← links)
- Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus (Q42726305) (← links)
- Treatment of human hepatocellular carcinoma by fibroblast-mediated human interferon ? gene therapy in combination with adoptive chemoimmunotherapy (Q42831503) (← links)
- A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma (Q43197898) (← links)
- Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis? (Q47734769) (← links)
- Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma (Q47869247) (← links)
- Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. (Q54234543) (← links)
- Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma (Q58022064) (← links)
- Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial (Q58236397) (← links)
- Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results of a western comparative study in 60 patients (Q67913757) (← links)
- Hepatocellular carcinoma (Q73328021) (← links)
- Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinoma (Q77668250) (← links)
- A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma (Q80376325) (← links)